Nucleus Formulation Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.57 Cr
- Satisfied Charges ₹ 5.83 Cr
- Revenue Growth 25.35%
- Profit Growth 485.44%
- Ebitda 53.22%
- Net Worth 40.66%
- Total Assets -27.46%
About Nucleus Formulation
Nucleus Formulation Private Limited (NFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 July 2009 and has a history of 15 years and seven months. Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.57 Cr. The company has closed loans amounting to ₹5.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Patel and Dipesh Thakar serve as directors at the Company.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239GJ2009PTC057517
- Company No.
057517
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Who are the key members and board of directors at Nucleus Formulation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Patel  | Director | 13-Jul-2009 | Current |
| Dipesh Thakar | Director | 13-Jul-2009 | Current |
Financial Performance of Nucleus Formulation.
Nucleus Formulation Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.35% increase. The company also saw a substantial improvement in profitability, with a 485.44% increase in profit. The company's net worth Soared by an impressive increase of 40.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nucleus Formulation?
Unlock access to Nucleus Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dipjyot Global Trade Private LimitedDipesh Thakar is a mutual person
Charges (Loans)
Open Charges
₹25.66 M
Satisfied Charges
₹58.30 M
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
- Sidbi : 0.53 Cr
- Hdfc Bank Limited : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2023 | Sidbi | ₹5.26 M | Open |
| 06 Jun 2023 | Others | ₹2.00 Cr | Open |
| 24 Jun 2021 | Hdfc Bank Limited | ₹0.40 M | Open |
| 11 Apr 2019 | Others | ₹2.50 Cr | Satisfied |
| 09 Oct 2014 | Hdfc Bank Limited | ₹1.36 Cr | Satisfied |
How Many Employees Work at Nucleus Formulation?
Nucleus Formulation has a workforce of 14 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nucleus Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleus Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
